Harrow Health
Price & Volume
Stats
See more52W Range | $20.85-$51.30 |
Market Cap | $1.8B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $250M |
Revenue Growth (YoY) | 45.4% |
Gross Profit (12 Mos) | $186.4M |
Diluted EPS | -$0.13 |
News
See moreYahoo Finance • 22 days ago
How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story
Yahoo Finance • last month
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
Yahoo Finance • 2 months ago
Harrow Health Q3 2025 Earnings Preview
Yahoo Finance • 2 months ago
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
About
CEO | Mr. Mark L. Baum J.D. |
CFO | Mr. Andrew R. Boll C.F.A., C.M.A. |
Address | 1A Burton Hills Boulevard, Nashville, TN, United States, 37215 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 382 |
